+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunodiagnostic Reagent Market Analysis, by Reagents, By Application, By End User Forecasts to 2027

  • PDF Icon


  • 143 Pages
  • August 2020
  • Region: Global
  • Reports and Data
  • ID: 5317678
Immunodiagnostic reagent (IR) test has been widely used for analysis of environment as well as food analysis in food industry, and in forensic laboratories, which is a key factor driving market revenue growth.

Market Size - USD 7,069.0 Million in 2020, Market Growth - CAGR of 12.8%, Market Trends - Increasing investment by major players in R&D of enhanced diagnosis tests, and growing adoption of next-gen automated immunodiagnostic reagent (IR) platform by clinicians.

The global immunodiagnostic reagent market size is expected to reach USD 18.60 Billion in 2028, and register a CAGR of 12.8% during the forecast period. Market growth is expected to be driven by factors including high prevalence of infectious diseases, endocrinology disorder, auto-immune diseases, and various other chronic diseases such as cancer and cardiovascular, coupled with increasing associated requirement for systems for early and timely diagnosis.

According to the Global Burden of Disease Study 2013, infectious disease caused around 9.2 Mn deaths globally, and has been registering an upward track since that year. This has compelled companies and government to increasing focus on development and launch of novel techniques, and equipment and tools, for early and timely diagnosis of diseases to manage and control growing disease-burden.

Some Key Findings From the Report:
  • Among the application segments, the cardiac biomarker segment accounted for the largest revenue share of 18.1% in 2020.
  • In 2020, the Asia Pacific market size was USD 1,625.9 Million, due to growing emergence of automation of laboratories, and increasing demand for immunodiagnostics with high prevalence of various infectious as well as chronic diseases in countries in the region.
  • Key players profiled in the report include Abbott Laboratories, Immunodiagnostic Reagent Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.
  • Other companies in the value chain are Alere, Inc., Arkray, Inc., Merck Millipore, Biomerieux SA, Becton, Dickinson and Company, Qiagen NV, Medicaroid Corporation, ImmunoDX, Affymetrix, and Meridian Bioscience, among others.
  • The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint. For instance in 2019, Oncimmune, which is a UK-based company, acquired a Germany-based personalized immuno-profiling company - Prottagen Diagnostics AG. Additionally in 2016, Diasorin acquired immunodiagnostic reagent products of Quest Diagnostics.

For the purpose of this report, the global immunodiagnostic reagent market is segmented on the basis of reagent, application, end-use, and region:

By Reagent
  • Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
  • Rapid Test Reagents and Kits
  • Enzyme-linked Immunospot ELISPOT Reagents and Kits
  • Western Blot Reagents and Kits
  • Other Reagents & Kits

By Application
  • Infectious Diseases
  • Hepatitis & retrovirus
  • Oncology & endocrinology
  • Bone & mineral
  • Autoimmunity
  • Cardiac biomarker
  • Others

By End Use
  • Clinical Laboratories
  • Hospitals
  • Academic & Research Centers
  • Pharmaceutical & Biotechnology Industry
  • Others

Region Outlook
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Reasons to Buy the Report
  • A robust analysis and estimation of the Immunodiagnostic Reagent Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in Immunodiagnostic Reagent Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization

Table of Contents

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2016 - 2026
Chapter 3. Indicative Metrics
Chapter 4. Immunodiagnostic Reagent Segmentation & Impact Analysis
4.1. Immunodiagnostic Reagent Segmentation Analysis
4.2. Pharmaceutical Industry Outlook
4.3. Regulatory Framework
4.4. ETOP Analysis
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
Chapter 5. Immunodiagnostic Reagent Market By Reagent Insights & Trends
5.1. Reagent Dynamics & Market Share, 2018 & 2026
5.2. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
5.3. Rapid Test Reagents and Kits
5.4. Enzyme-linked Immunospot ELISPOT Reagents and Kits
5.5. Western Blot Reagents and Kits
5.6. Other Reagents & Kits
Chapter 6. Immunodiagnostic Reagent Market By Application Insights & Trends
6.1. Application Dynamics & Market Share, 2018 & 2026
6.2. Infectious Diseases
6.3. Hepatitis & retrovirus
6.4. Oncology & endocrinology
6.5. Bone & mineral
6.6. Autoimmunity
6.7. Cardiac biomarker
6.8. Other Applications
Chapter 7. Immunodiagnostic Reagent Market By End User Insights & Trends
7.1. End User Dynamics & Market Share, 2018 & 2026
7.2. Clinical laboratories
7.3. Hospitals
7.4. Academic & Research Centers
7.5. Pharmaceutical & Biotechnology Industry
7.6. Other End Users
Chapter 8. Immunodiagnostic Reagent Market Regional Outlook
8.1. Immunodiagnostic Reagent Market share by region, 2017 & 2026
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. MEA
8.6. Latin America
Chapter 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Mergers & Acquisitions
9.3. Market positioning
9.4. Strategy Benchmarking
9.5. Vendor Landscape
Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.2. Immunodiagnostic Reagent Systems Holdings Plc (IDS)
10.3. DiaSorin S.p.A.
10.4. Johnson & Johnson
10.5. F. Hoffmann-La Roche Ltd
10.6. Siemens AG
10.7. Sysmex Corporation
10.8. Danaher Corporation
10.9. Thermo Fisher Scientific Inc.
10.10. Bio-Rad Laboratories, Inc.

Companies Mentioned

  • Abbott Laboratories
  • Immunodiagnostic Reagent Systems Holdings Plc (IDS)
  • DiaSorin SpA
  • Johnson & Johnson
  • F Hoffmann-La Roche Ltd
  • Siemens AG
  • Sysmex Corporation
  • Danaher Corporation
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Arkray Inc